It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Several studies have reported that weight control is of paramount importance in reducing the risk of metabolic syndrome. Nevertheless, this well-known association does not provide any practical information on how much weight loss in a given period would reduce the risk of metabolic syndrome in individuals in a personalized setting. This study aimed to develop and validate a risk prediction model for metabolic syndrome in 2 years, based on an individual’s baseline health status and body weight after 2 years. We recruited 3,447 and 3,874 participants from the Ansan and Anseong cohorts of the Korean Genome and Epidemiology Study, respectively. Among the former, 8636 longitudinal observations of 2,412 participants (70%) and 3,570 of 1,034 (30%) were used for training and internal validation, respectively. Among the latter, all 15,739 observations of 3,874 participants were used for external validation. Compared to logistic regression, Gaussian Naïve Bayes, random forest, and deep neural network, XGBoost showed the highest performance (area under curve of 0.879) and a significantly enhanced calibration of the predictive score with the prevalence rate. The model was ported onto an application to provide the 2-year probability of developing metabolic syndrome by simulating selected target body weights, based on an individual’s baseline health profiles. Further prospective studies are required to determine whether weight-control programs could lead to favorable health outcomes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); Department of Dermatology, Yonsei University Wonju Severance Christian Hospital, Wonju, Republic of Korea (GRID:grid.464718.8) (ISNI:0000 0004 0647 3124)
2 Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
3 Institute of Genomic Cohort, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)